Recombinant PLAP antibody (N-Term)
Quick Overview for Recombinant PLAP antibody (N-Term) (ABIN5708191)
Target
See all PLAP (ALPP) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- N-Term
-
Purpose
- Recombinant PLAP Antibody / Placental Alkaline Phosphatase / N-Terminal
-
Purification
- Protein A purified from animal origin-free supernatant
-
Immunogen
- A peptide corresponding to the N-terminus of human placental alkaline phosphatase was used as the immunogen for the recombinant PLAP antibody.
-
Isotype
- IgG
-
-
-
-
Application Notes
- The stated application concentrations are suggested starting points. Titration of the recombinant PLAP antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Antibody in PBS with 50 % glycerol, 1 % BSA and 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store the recombinant PLAP antibody at -20oC.
-
-
- PLAP (ALPP) (Placental Alkaline Phosphatase (ALPP))
-
Alternative Name
- PLAP
-
Background
-
Alkaline phosphatase, placental type is a membrane-bound glycosylated dimeric enzyme, also referred to as the heat-stable form, that is expressed primarily in the placenta, although it is closely related to the intestinal form of the enzyme as well as to the placental-like form.
PLAP is a tumor marker, especially in seminoma and ovarian cancer. PLAP is reliable only in non-smokers, as smoking interferes with measurement of PLAP, since serum concentrations of PLAP are increased up to 10-fold in smokers and its measurement is therefore of little value in this group. [Wiki] -
UniProt
- P05187
Target
-